This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Superficial vein thrombosis (SVT) treated for fort...
Clinical trial

Superficial vein thrombosis (SVT) treated for forty-five days with Rivaroxaban versus Fondaparinux

Read time: 1 mins
Last updated:23rd Dec 2011
Evaluation of efficacy and safety of 45 days of rivaroxaban 10 mg vs. fondaparinux 2.5 mg in the treatment of superficial vein thrombosis of risk patients for major VTE complications to prove non-inferiority of oral rivaroxaban treatment
Category Value
Study start date 2011-12-23

View full details